NCT05145010 Extension Study of Infigratinib in Children With Achondroplasia (ACH) Status ENROLLING_BY_INVITATION Phase PHASE2
NCT05116046 Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia Status TERMINATED Phase PHASE2
NCT04638153 A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia Status TERMINATED Phase PHASE2
NCT04554940 A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04085523 A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia Status COMPLETED Phase PHASE2
NCT04035811 Prospective Clinical Assessment Study in Children With Achondroplasia (ACH) Status COMPLETED Phase N/A
NCT03989947 An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03875534 A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia Status COMPLETED Phase N/A
NCT03794609 Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia. Status TERMINATED Phase N/A
NCT03583697 A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia Status COMPLETED Phase PHASE2
NCT03424018 An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03197766 A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia Status COMPLETED Phase PHASE3
NCT02724228 A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02055157 A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia Status COMPLETED Phase PHASE2